Our results are broadly similar to the extensive published data [[5], [6], [7], [8], [9], [10], [11],16,17] and show that patients with a positive PR tumour have a better survival than patients with a PR-negative tumour regardless of their ER status. The gene discussed is PGR; the disease is neoplasm.